BeiGene Ltd

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
BeiGene Ltd
TickerBGNE
CIK #0001651308
CUSIP07725L102
SectorLife Sciences - Pharmaceutical Preparations
Addressc/o Mourant Ozannes Corporate Services 94 Solaris Avenue, Camana Bay, Grand Cayman, KY1-1108
Source [EDGAR]
CIK Filing 2011 - 2024
[0001651308] 10-K
[0001651308] 10-Q
[0001651308] 3
[0001651308] 4
[0001651308] 5
[0001651308] 8-K
[0001651308] SC 13D
[0001651308] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Invesco Ltd BeiGene Ltd [2022-02-11] 5.6
BeiGene Ltd LEAP Therapeutics Inc [2020-03-23] 23.7
Capital International Investors BeiGene Ltd [2020-01-10] 10.0
Amgen Inc BeiGene Ltd [2020-01-08] 20.5
BeiGene Ltd BeiGene Ltd [2019-02-12] 0.4
Wellington Management Group LLP BeiGene Ltd [2018-02-08] 8.39
Celgene Corp /DE/ BeiGene Ltd [2017-09-01] 5.6
Oyler John BeiGene Ltd [2017-02-13] 15.8
FMR LLC BeiGene Ltd [2017-01-10] 0.0
Hillhouse Capital Management Ltd BeiGene Ltd [2016-02-18] 0.29
Merck & Co Inc BeiGene Ltd [2016-02-12] 7.4
Baker Bros Advisors LP BeiGene Ltd [2016-02-09] 24.6
Form 3/4/5 Filer 2011 - 2024
BeiGene, Ltd.
Hillhouse Investment Management Ltd
HHLR Advisors Ltd
Wu Xiaobin
Wang Lai
Wang Xiaodong
Wang Julia Aijun
Oyler John
Yi Qingqing
Dugan Margaret
Baker Julian
Baker Bros Advisors LP
667 LP
Baker Felix
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Hooper Anthony C
Glazer Donald W.
Riva Alessandro
Sanders Corazon (Corsee) D.
Malley Thomas
Huang Jane
LEAP Therapeutics Inc
Amgen Inc
Liang Howard
su Jingshyh S
Chen Timothy Yung-Cheng
Peterson Amy C.
Li Ji
14159 LP
Tang Ke
Yang Jianxin
Yan Wendy Xiaojun
Merck Sharp & Dohme Corp.
Merck & Co., Inc.
Merck Sharp & Dohme Research GmbH
CITIC PE Associates, L.P.
CB Biotech Investment Ltd
CPEChina Fund, L.P.
CITIC PE Funds Ltd
Yuan RuiRong
Goller Michael
Krishana Ranjeev
Form 13F Holdings
Firm Period DFND Voting Shares
Baker Bros Advisors LP [2023-03-31] SOLE 11,668,897.0 11,668,897.0
Capital International Investors [2023-03-31] DFND 6,545,078.0 6,565,599.0
HHLR Advisors Ltd [2023-03-31] OTR 0.0 5,472,259.0
PRIMECAP Management Co/CA/ [2023-03-31] SOLE 4,935,549.0 5,045,924.0
Temasek Holdings (Private) Ltd [2023-03-31] DFND 2,966,463.0 2,966,463.0
Baillie Gifford & Co [2023-03-31] DFND 1,398,376.0 2,656,553.0
FMR LLC [2023-03-31] DFND 2,481,745.0 2,500,356.0
Invesco Ltd. [2023-03-31] DFND 0.0 1,572,341.0
Capital International, Inc./CA/ [2023-03-31] DFND 913,152.0 997,042.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 126,105.0 774,357.0
BlackRock Inc. [2023-03-31] SOLE 705,361.0 705,808.0
Baillie Gifford & Co [2023-03-31] SOLE 281,566.0 660,809.0
Artal Group S.A. [2023-03-31] DFND 501,335.0 501,335.0
Boxer Capital, LLC [2023-03-31] OTR 500,000.0 500,000.0
Public Investment Fund [2023-03-31] SOLE 317,685.0 317,685.0
Bank of America Corp /DE/ [2023-03-31] DFND 2,201.0 310,761.0
State Street Corp [2023-03-31] DFND 264,411.0 266,211.0
Capital Group Private Client Services Inc [2023-03-31] DFND 244,814.0 246,139.0
Fairmount Funds Management LLC [2023-03-31] SOLE 239,443.0 239,443.0
Paradigm Biocapital Advisors LP [2023-03-31] SOLE 184,012.0 184,012.0
Axiom Investors LLC /DE [2023-03-31] SOLE 122,273.0 165,676.0
Morgan Stanley [2023-03-31] DFND 145,641.0 155,906.0
Capital International SARL [2023-03-31] DFND 148,462.0 152,957.0
Zeal Asset Management Ltd [2023-03-31] SOLE 0.0 139,904.0
M&G Investment Management Ltd [2023-03-31] SOLE 137,642.0 137,642.0
Matthews International Capital Management LLC [2023-03-31] SOLE 136,958.0 136,958.0
Bridgewater Associates LP [2023-03-31] SOLE 132,117.0 132,117.0
Pictet Asset Management Sa [2023-03-31] DFND 1.0 112,940.0
Baird Financial Group, Inc. [2023-03-31] DFND 315.0 106,206.0
Mitsubishi UFJ Trust & Banking Corp [2023-03-31] SOLE 105,164.0 105,164.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com